These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3840066)

  • 1. The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects.
    Cohen AF; Hamilton M; Philipson R; Peck AW
    Clin Pharmacol Ther; 1985 Oct; 38(4):381-6. PubMed ID: 3840066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of acrivastine (BW825C), diphenhydramine and terfenadine in combination with alcohol on human CNS performance.
    Cohen AF; Hamilton MJ; Peck AW
    Eur J Clin Pharmacol; 1987; 32(3):279-88. PubMed ID: 2885203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of triprolidine and cyclizine on histamine (H1) antagonism, subjective effects and performance tests in man.
    Hamilton M; Bush M; Bye C; Peck AW
    Br J Clin Pharmacol; 1982 Mar; 13(3):441-4. PubMed ID: 6120718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria.
    Neittaanmäki H; Fräki JE; Gibson JR
    Dermatologica; 1988; 177(2):98-103. PubMed ID: 2901993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar.
    Williams BO; Hull H; McSorley P; Frosolono MF; Sanders RL
    Ann Allergy Asthma Immunol; 1996 May; 76(5):432-8. PubMed ID: 8630717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic and pharmacokinetics of BW 825C: a new antihistamine.
    Cohen AF; Hamilton MJ; Liao SH; Findlay JW; Peck AW
    Eur J Clin Pharmacol; 1985; 28(2):197-204. PubMed ID: 2859204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the antihistamine activity of acrivastine and its onset in human skin.
    Manna VK; Marks P; Gibson JR
    J Int Med Res; 1992 Apr; 20(2):106-11. PubMed ID: 1355745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers.
    Rolan PE; Adams J; Posner J
    J Int Med Res; 1989; 17 Suppl 2():35B-39B. PubMed ID: 2570000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing.
    Ramaekers JG; O'Hanlon JF
    Eur J Clin Pharmacol; 1994; 47(3):261-6. PubMed ID: 7867679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of triprolidine and clemastine on histamine antagonism and performance tests in man: implications for the mechanism of drug induced drowsiness.
    Peck AW; Fowle AS; Bye C
    Eur J Clin Pharmacol; 1975 Aug; 8(6):455-63. PubMed ID: 1233248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers.
    Rolan PE; Phillips S; Adams J; Posner J
    Eur J Clin Pharmacol; 1990; 39(3):311-3. PubMed ID: 1979541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of triprolidine and dipipanone in the cold induced pain test, and the central nervous system of healthy volunteers.
    Telekes A; Holland RL; Withington DA; Peck AW
    Br J Clin Pharmacol; 1987 Jul; 24(1):43-50. PubMed ID: 3620284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acrivastine--an evaluation of initial and peak activity in human skin.
    Marks P; Manna VK; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrivastine in seasonal allergic rhinitis: two randomized crossover studies to evaluate efficacy and safety.
    Gibbs TG; Irander K; Salo OP
    J Int Med Res; 1988; 16(6):413-9. PubMed ID: 2906886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acrivastine in allergic rhinitis: a review of clinical experience.
    Bojkowski CJ; Gibbs TG; Hellstern KH; Major EW; Mullinger B
    J Int Med Res; 1989; 17 Suppl 2():54B-68B. PubMed ID: 2570003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders.
    Brogden RN; McTavish D
    Drugs; 1991 Jun; 41(6):927-40. PubMed ID: 1715267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acrivastine--a new antihistaminic].
    Bindslev-Jensen C; Thestrup-Pedersen K
    Ugeskr Laeger; 1990 Jul; 152(28):2062-3. PubMed ID: 1973315
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed.
    Dockhorn RJ; Williams BO; Sanders RL
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):204-8. PubMed ID: 8595542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two antihistamine drugs on actual driving performance.
    Betts T; Markman D; Debenham S; Mortiboy D; McKevitt T
    Br Med J (Clin Res Ed); 1984 Jan; 288(6413):281-2. PubMed ID: 6140978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis.
    Meran A; Morse J; Gibbs TG
    Rhinology; 1990 Mar; 28(1):33-40. PubMed ID: 1970907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.